Skip to content

Clinical trials

Completed Lung Neoplasms trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Completed Country / region: Israel Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20082
20091
20104
20111
20123
20132
20142
20154
20161
20171
20181
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
AstraZeneca2
Bristol-Myers Squibb2
Eli Lilly and Company2
Fore Biotherapeutics2
Gustave Roussy, Cancer Campus, Grand Paris2
InSightec2
Incyte Corporation2
Nucleix Ltd.2
Achieve Life Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms31
Carcinoma, Non-Small-Cell Lung14
Adenocarcinoma of Lung5
Breast Neoplasms5
Neoplasm Metastasis4
Neoplasms4
Prostatic Neoplasms3
Bone Neoplasms2
Cancer Pain2
Colonic Neoplasms2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.